{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T21:48:41Z","timestamp":1780436921035,"version":"3.54.1"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2008,6,17]],"date-time":"2008-06-17T00:00:00Z","timestamp":1213660800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1038\/ncpneph0854","type":"journal-article","created":{"date-parts":[[2008,6,17]],"date-time":"2008-06-17T12:19:09Z","timestamp":1213705149000},"page":"446-457","source":"Crossref","is-referenced-by-count":69,"title":["A primer on recurrent and de novo glomerulonephritis in renal allografts"],"prefix":"10.1038","volume":"4","author":[{"given":"Bela","family":"Ivanyi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,6,17]]},"reference":[{"key":"BFncpneph0854_CR1","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1111\/j.1523-1755.2004.00655.x","volume":"65","author":"U Yakupoglu","year":"2004","unstructured":"Yakupoglu U et al. (2004) Post-transplant nephrotic syndrome: a comprehensive clinicopathologic study. Kidney Int 65: 2360\u20132370","journal-title":"Kidney Int"},{"key":"BFncpneph0854_CR2","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1034\/j.1399-0012.2000.140509.x","volume":"14","author":"J Chung","year":"2000","unstructured":"Chung J et al. (2000) Glomerulonephritis is the major cause of proteinuria in renal transplant recipients: histopathologic findings of renal allografts with proteinuria. Clin Transplant 14: 499\u2013504","journal-title":"Clin Transplant"},{"key":"BFncpneph0854_CR3","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1046\/j.1523-1755.63.6s.2.x","volume":"63","author":"H Suzuki","year":"2003","unstructured":"Suzuki H et al. (2003) Incidence of latent mesangial IgA deposition in renal allograft donors in Japan. Kidney Int 63: 2286\u20132294","journal-title":"Kidney Int"},{"issue":"Suppl 14","key":"BFncpneph0854_CR4","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1111\/j.1399-0012.2005.00403.x","volume":"19","author":"T Moriyama","year":"2005","unstructured":"Moriyama T et al. (2005) Latent IgA deposition from donor kidney is the major risk factor for recurrent IgA nephropathy in renal transplantation. Clin Transplant 19 (Suppl 14): S41\u2013S48","journal-title":"Clin Transplant"},{"key":"BFncpneph0854_CR5","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1111\/j.1600-6143.2005.00922.x","volume":"5","author":"MS Schwartzman","year":"2005","unstructured":"Schwartzman MS et al. (2005) Transplantation and 6-month follow-up of renal transplantation from a donor with systemic lupus erythematosus and lupus nephritis. Am J Transplant 5: 1772\u20131776","journal-title":"Am J Transplant"},{"key":"BFncpneph0854_CR6","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1093\/ndt\/14.3.564","volume":"14","author":"JD Briggs","year":"1999","unstructured":"Briggs JD and Jones E (1999) Recurrence of glomerulonephritis following renal transplantation. Nephrol Dial Transplant 14: 564\u2013565","journal-title":"Nephrol Dial Transplant"},{"key":"BFncpneph0854_CR7","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1681\/ASN.V122394","volume":"12","author":"S Chadban","year":"2001","unstructured":"Chadban S (2001) Glomerulonephritis recurrence in the renal graft. J Am Soc Nephrol 12: 394\u2013402","journal-title":"J Am Soc Nephrol"},{"key":"BFncpneph0854_CR8","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1053\/ajkd.1998.v31.pm9631835","volume":"31","author":"S Hariharan","year":"1998","unstructured":"Hariharan S et al. (1998) Recurrent and de novo renal diseases after renal transplantation: a report from the Renal Allograft Disease Registry. Am J Kidney Dis 31: 928\u2013931","journal-title":"Am J Kidney Dis"},{"key":"BFncpneph0854_CR9","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1097\/00007890-199909150-00007","volume":"68","author":"S Hariharan","year":"1999","unstructured":"Hariharan S et al. (1999) Recurrent and de novo glomerular disease after renal transplantation: a report from Renal Allograft Disease Registry (RADR). Transplantation 68: 635\u2013641","journal-title":"Transplantation"},{"key":"BFncpneph0854_CR10","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1056\/NEJMoa013036","volume":"347","author":"EM Briganti","year":"2002","unstructured":"Briganti EM et al. (2002) Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med 347: 103\u2013109","journal-title":"N Engl J Med"},{"key":"BFncpneph0854_CR11","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1097\/01.TP.0000128612.75163.26","volume":"78","author":"BJ Nankivell","year":"2004","unstructured":"Nankivell BJ et al. (2004) Evolution and pathophysiology of renal-transplant glomerulosclerosis. Transplantation 78: 461\u2013468","journal-title":"Transplantation"},{"key":"BFncpneph0854_CR12","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1097\/01.tp.0000188656.44326.53","volume":"81","author":"H Ibrahim","year":"2006","unstructured":"Ibrahim H et al. (2006) Graft loss from recurrent glomerulonephritis is not increased with a rapid steroid discontinuation protocol. Transplantation 81: 214\u2013219","journal-title":"Transplantation"},{"issue":"Suppl 2","key":"BFncpneph0854_CR13","doi-asserted-by":"publisher","first-page":"251S","DOI":"10.1016\/j.transproceed.2004.01.027","volume":"36","author":"K Morozumi","year":"2004","unstructured":"Morozumi K et al. (2004) Cyclosporine nephrotoxicity: how does it affect renal allograft function and transplant morphology? Transplant Proc 36 (Suppl 2): 251S\u2013256S","journal-title":"Transplant Proc"},{"key":"BFncpneph0854_CR14","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/S0272-6386(99)70400-2","volume":"34","author":"FG Cosio","year":"1999","unstructured":"Cosio FG et al. (1999) Focal segmental glomerulosclerosis in renal allografts with chronic nephropathy: implications for graft survival. Am J Kidney Dis 34: 731\u2013738","journal-title":"Am J Kidney Dis"},{"key":"BFncpneph0854_CR15","first-page":"32","volume":"22","author":"S Zimmerman","year":"1984","unstructured":"Zimmerman S (1984) Increased urinary protein excretion in the rat produced by serum from a patient with recurrent focal glomerular sclerosis after renal transplantation. Clin Nephrol 22: 32\u201338","journal-title":"Clin Nephrol"},{"key":"BFncpneph0854_CR16","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1097\/00007890-200202150-00009","volume":"73","author":"M Sharma","year":"2002","unstructured":"Sharma M et al. (2002) Proteinuria after injection of human focal segmental glomerulosclerosis factor. Transplantation 73: 366\u2013372","journal-title":"Transplantation"},{"key":"BFncpneph0854_CR17","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/1615-9861(200202)2:2<197::AID-PROT197>3.0.CO;2-6","volume":"2","author":"L Musante","year":"2002","unstructured":"Musante L et al. (2002) Characterization of plasma factors that alter the permeability to albumin within isolated glomeruli. Proteomics 2: 197\u2013205","journal-title":"Proteomics"},{"key":"BFncpneph0854_CR18","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1681\/ASN.2004030172","volume":"16","author":"RJ Coward","year":"2005","unstructured":"Coward RJ et al. (2005) Nephrotic plasma alters slit diaphragm-dependent signaling and translocates nephrin, podocin, and CD2 associated protein in cultured human podocytes. J Am Soc Nephrol 16: 629\u2013637","journal-title":"J Am Soc Nephrol"},{"key":"BFncpneph0854_CR19","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1097\/01.ASN.0000060578.79050.E0","volume":"14","author":"G Caridi","year":"2003","unstructured":"Caridi G et al. (2003) Broadening the spectrum of diseases related to podocin mutations. J Am Soc Nephrol 14: 1278\u20131286","journal-title":"J Am Soc Nephrol"},{"key":"BFncpneph0854_CR20","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1046\/j.1523-1755.2003.00084.x","volume":"64","author":"G Caridi","year":"2003","unstructured":"Caridi G et al. (2003) Podocin mutations in sporadic focal-segmental glomerulosclerosis occurring in adulthood. Kidney Int 64: 365","journal-title":"Kidney Int"},{"key":"BFncpneph0854_CR21","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1097\/01.ASN.0000113552.59155.72","volume":"15","author":"R Ruf","year":"2004","unstructured":"Ruf R et al. (2004) Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome. J Am Soc Nephrol 15: 722\u2013732","journal-title":"J Am Soc Nephrol"},{"key":"BFncpneph0854_CR22","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/j.1523-1755.2004.00776.x","volume":"66","author":"S Weber","year":"2004","unstructured":"Weber S et al. (2004) NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low post-transplant recurrence. Kidney Int 66: 571\u2013579","journal-title":"Kidney Int"},{"key":"BFncpneph0854_CR23","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1097\/01.ASN.0000016445.29513.AB","volume":"13","author":"M Carraro","year":"2002","unstructured":"Carraro M et al. (2002) Serum glomerular permeability activity in patients with podocin mutations (NPHS2) and steroid-resistant nephrotic syndrome. J Am Soc Nephrol 13: 1946\u20131952","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 6","key":"BFncpneph0854_CR24","first-page":"Svi68","volume":"18","author":"CG Newstead","year":"2003","unstructured":"Newstead CG (2003) Recurrent disease in renal transplants. Nephrol Dial Transplant 18 (Suppl 6): Svi68\u2013Svi74","journal-title":"Nephrol Dial Transplant"},{"key":"BFncpneph0854_CR25","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1093\/ndt\/gfl225","volume":"21","author":"S Swaminathan","year":"2006","unstructured":"Swaminathan S et al. (2006) Collapsing and non-collapsing focal segmental glomerulosclerosis in kidney transplants. Nephrol Dial Transplant 21: 2607\u20132614","journal-title":"Nephrol Dial Transplant"},{"key":"BFncpneph0854_CR26","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1159\/000101371","volume":"27","author":"HE Adrogue","year":"2007","unstructured":"Adrogue HE et al. (2007) Coincident activation of Th2 T cells with onset of the disease and differential expression of GRO-gamma in peripheral blood leukocytes in minimal change disease. Am J Nephrol 27: 253\u2013261","journal-title":"Am J Nephrol"},{"key":"BFncpneph0854_CR27","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1034\/j.1399-0012.2002.02023.x","volume":"16","author":"A Zafarmand","year":"2002","unstructured":"Zafarmand A et al. (2002) De novo minimal change disease associated with reversible post-transplant nephrotic syndrome: a report of five cases and review of literature. Clin Transplant 16: 350\u2013361","journal-title":"Clin Transplant"},{"key":"BFncpneph0854_CR28","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1681\/ASN.2004121080","volume":"16","author":"P Ronco","year":"2005","unstructured":"Ronco P and Debiec H (2005) Molecular pathomechanisms of membranous nephropathy: from Heymann nephritis to alloimmunization. J Am Soc Nephrol 16: 1205\u20131213","journal-title":"J Am Soc Nephrol"},{"key":"BFncpneph0854_CR29","first-page":"144","volume":"50","author":"JP Cosyns","year":"1998","unstructured":"Cosyns JP et al. (1998) Recurrence of membranous nephropathy after renal transplantation: probability, outcome and risk factors. Clin Nephrol 50: 144\u2013153","journal-title":"Clin Nephrol"},{"key":"BFncpneph0854_CR30","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/j.1399-0012.2007.00650.x","volume":"21","author":"R Requiao-Moura","year":"2007","unstructured":"Requiao-Moura R et al. (2007) Prognostic factors associated with poor graft outcomes in renal recipients with post-transplant glomerulonephritis. Clin Transplant 21: 363\u2013370","journal-title":"Clin Transplant"},{"key":"BFncpneph0854_CR31","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1097\/00007890-199409270-00002","volume":"58","author":"A Schwarz","year":"1994","unstructured":"Schwarz A et al. (1994) Impact of de novo membranous glomerulonephritis on the clinical course after kidney transplantation. Transplantation 58: 650\u2013654","journal-title":"Transplantation"},{"key":"BFncpneph0854_CR32","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/S0270-9295(03)00057-3","volume":"23","author":"RD Poduval","year":"2003","unstructured":"Poduval RD et al. (2003) Treatment of de novo and recurrent membranous nephropathy in renal transplant recipients. Semin Nephrol 23: 392\u2013399","journal-title":"Semin Nephrol"},{"key":"BFncpneph0854_CR33","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/j.1600-6143.2005.00690.x","volume":"5","author":"SA Joosten","year":"2005","unstructured":"Joosten SA et al. (2005) Antibody response against the glomerular basement membrane protein agrin in patients with transplant glomerulopathy. Am J Transplant 5: 383\u2013393","journal-title":"Am J Transplant"},{"key":"BFncpneph0854_CR34","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s00281-007-0090-3","volume":"29","author":"SP Berger","year":"2007","unstructured":"Berger SP and Daha MR (2007) Complement in glomerular injury. Semin Immunopathol 29: 375\u2013384","journal-title":"Semin Immunopathol"},{"key":"BFncpneph0854_CR35","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1681\/ASN.2005020175","volume":"16","author":"MC Braun","year":"2005","unstructured":"Braun MC et al. (2005) Recurrence of membranoproliferative glomerulonephritis type II in renal allografts: the North American Pediatric Renal Transplant Cooperative Study Experience. J. Am Soc Nephrol 16: 2225\u20132233","journal-title":"J. Am Soc Nephrol"},{"key":"BFncpneph0854_CR36","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/sj.ki.5000084","volume":"69","author":"MA Little","year":"2006","unstructured":"Little MA et al. (2006) Severity of primary MPGN, rather than MPGN type, determines renal survival and post-transplantation recurrence risk. Kidney Int 69: 504\u2013511","journal-title":"Kidney Int"},{"key":"BFncpneph0854_CR37","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.7326\/0003-4819-134-11-200106050-00009","volume":"134","author":"J Levy","year":"2001","unstructured":"Levy J et al. (2001) Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. Ann Intern Med 134: 1033\u20131042","journal-title":"Ann Intern Med"},{"key":"BFncpneph0854_CR38","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1093\/ndt\/gfg393","volume":"19","author":"M Khandelwal","year":"2004","unstructured":"Khandelwal M et al. (2004) Recurrence of anti-GBM disease 8 years after renal transplantation. Nephrol Dial Transplant 19: 491\u2013494","journal-title":"Nephrol Dial Transplant"},{"key":"BFncpneph0854_CR39","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1053\/j.ajkd.2004.09.029","volume":"45","author":"DB Borza","year":"2005","unstructured":"Borza DB et al. (2005) Recurrent Goodpasture's disease secondary to a monoclonal IgA1-kappa antibody autoreactive with the alpha1\/alpha2 chains of type IV collagen. Am J Kidney Dis 45: 397\u2013406","journal-title":"Am J Kidney Dis"},{"key":"BFncpneph0854_CR40","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1046\/j.1523-1755.1999.00666.x","volume":"56","author":"PH Nachman","year":"1999","unstructured":"Nachman PH et al. (1999) Recurrent ANCA-associated small vessel vasculitis after transplantation: a pooled analysis. Kidney Int 56: 1544\u20131550","journal-title":"Kidney Int"},{"key":"BFncpneph0854_CR41","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1093\/ndt\/gfg087","volume":"18","author":"A Elmedhem","year":"2003","unstructured":"Elmedhem A et al. (2003) Relapse rate and outcome of ANCA-associated small vessel vasculitis after transplantation. Nephrol Dial Transplant 18: 1001\u20131004","journal-title":"Nephrol Dial Transplant"},{"key":"BFncpneph0854_CR42","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1111\/j.1600-6143.2006.01502.x","volume":"6","author":"BY Choy","year":"2006","unstructured":"Choy BY et al. (2006) Recurrent glomerulonephritis after kidney transplantation. Am J Transplant 6: 2535\u20132542","journal-title":"Am J Transplant"},{"key":"BFncpneph0854_CR43","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1038\/sj.ki.5002244","volume":"71","author":"M Gera","year":"2007","unstructured":"Gera M et al. (2007) Recurrence of ANCA-associated vasculitis following renal transplantation in the modern era of immunosupression. Kidney Int 71: 1296\u20131301","journal-title":"Kidney Int"},{"key":"BFncpneph0854_CR44","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00281-007-0089-9","volume":"29","author":"J Barratt","year":"2007","unstructured":"Barratt J et al. (2007) Immunopathogenesis of IgAN. Semin Immunopathol 29: 427\u2013443","journal-title":"Semin Immunopathol"},{"key":"BFncpneph0854_CR45","doi-asserted-by":"crossref","first-page":"231","DOI":"10.5858\/2005-129-231-RADNGI","volume":"129","author":"J Gough","year":"2005","unstructured":"Gough J et al. (2005) Recurrent and de novo glomerular immune-complex deposits in renal transplant biopsies. Arch Pathol Lab Med 129: 231\u2013233","journal-title":"Arch Pathol Lab Med"},{"key":"BFncpneph0854_CR46","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1097\/00007890-199804270-00008","volume":"65","author":"GL Bumgardner","year":"1998","unstructured":"Bumgardner GL et al. (1998) Single-center long-term results of renal transplantation for IgA nephropathy. Transplantation 65: 1053\u20131060","journal-title":"Transplantation"},{"key":"BFncpneph0854_CR47","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.3349\/ymj.2004.45.6.1043","volume":"45","author":"HJ Jeong","year":"2004","unstructured":"Jeong HJ et al. (2004) IgA nephropathy in renal allografts\u2014recurrence and graft dysfunction. Yonsei Med J 45: 1043\u20131048","journal-title":"Yonsei Med J"},{"key":"BFncpneph0854_CR48","doi-asserted-by":"publisher","first-page":"92","DOI":"10.4103\/0022-3859.32207","volume":"53","author":"B Chacko","year":"2007","unstructured":"Chacko B et al. (2007) Outcomes of renal transplantation in patients with immunoglobulin A nephropathy in India. J Postgrad Med 53: 92\u201395","journal-title":"J Postgrad Med"},{"key":"BFncpneph0854_CR49","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1093\/ndt\/gfg373","volume":"18","author":"BY Choy","year":"2003","unstructured":"Choy BY et al. (2003) Renal transplantation in patients with primary immunoglobulin A nephropathy. Nephrol Dial Transplant 18: 2399\u20132404","journal-title":"Nephrol Dial Transplant"},{"key":"BFncpneph0854_CR50","first-page":"279","volume":"56","author":"MB Andresdottir","year":"2001","unstructured":"Andresdottir MB et al. (2001) Favorable outcome of renal transplantation in patients with IgA nephropathy. Clin Nephrol 56: 279\u2013288","journal-title":"Clin Nephrol"},{"key":"BFncpneph0854_CR51","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1053\/ajkd.2001.26885","volume":"38","author":"AY Wang","year":"2001","unstructured":"Wang AY et al. (2001) Recurrent IgA nephropathy in renal transplant allografts. Am J Kidney Dis 38: 588\u2013596","journal-title":"Am J Kidney Dis"},{"key":"BFncpneph0854_CR52","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1097\/01.tp.0000230131.66971.45","volume":"82","author":"S McDonald","year":"2006","unstructured":"McDonald S et al. (2006) Recurrence of IgA nephropathy among renal allograft recipients from living donors is greater among those with zero HLA mismatches. Transplantation 82: 759\u2013762","journal-title":"Transplantation"},{"key":"BFncpneph0854_CR53","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1111\/j.1440-1827.2004.01751.x","volume":"54","author":"HJ Jeong","year":"2004","unstructured":"Jeong HJ et al. (2004) Glomerular crescents are responsible for chronic graft dysfunction in post-transplant IgA nephropathy. Pathol Int 54: 837\u2013842","journal-title":"Pathol Int"},{"key":"BFncpneph0854_CR54","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/j.1399-0012.2007.00730.x","volume":"21","author":"R Coppo","year":"2007","unstructured":"Coppo R et al. (2007) Serological and genetic factors in early recurrence of IgA nephropathy after renal transplantation. Clin Transplant 21: 728\u2013737","journal-title":"Clin Transplant"},{"key":"BFncpneph0854_CR55","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1111\/j.1399-3046.2006.00528.x","volume":"10","author":"CE Kashtan","year":"2006","unstructured":"Kashtan CE (2006) Renal transplantation in patients with Alport syndrome. Pediatr Transplant 10: 651\u2013657","journal-title":"Pediatr Transplant"},{"key":"BFncpneph0854_CR56","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1097\/01.ASN.0000090034.71205.74","volume":"14","author":"JP Jais","year":"2003","unstructured":"Jais JP et al. (2003) X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a \u201cEuropean Community Alport Syndrome Concerted Action\u201d study. J Am Soc Nephrol 14: 2603\u20132610","journal-title":"J Am Soc Nephrol"},{"key":"BFncpneph0854_CR57","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1097\/01.TP.0000085083.74065.1B","volume":"76","author":"MA Artz","year":"2003","unstructured":"Artz MA et al. (2003) Renal transplantation in patients with hemolytic uremic syndrome: high rate of recurrence and increased incidence of acute rejections. Transplantation 76: 821\u2013826","journal-title":"Transplantation"},{"key":"BFncpneph0854_CR58","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1182\/blood-2005-10-007252","volume":"108","author":"J Caprioli","year":"2006","unstructured":"Caprioli J et al. (2006) Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment and outcome. Blood 108: 1267\u20131279","journal-title":"Blood"},{"key":"BFncpneph0854_CR59","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1111\/j.1432-2277.2006.00354.x","volume":"19","author":"C Ponticelli","year":"2006","unstructured":"Ponticelli C and Banfi G (2006) Thrombotic microangiopathy after kidney transplantation. Transpl Int 19: 789\u2013794","journal-title":"Transpl Int"},{"key":"BFncpneph0854_CR60","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1681\/ASN.2006080811","volume":"18","author":"A Sellier-Leclerc","year":"2007","unstructured":"Sellier-Leclerc A et al. (2007) Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome. J Am Soc Nephrol 18: 2392\u20132400","journal-title":"J Am Soc Nephrol"},{"key":"BFncpneph0854_CR61","doi-asserted-by":"publisher","first-page":"88","DOI":"10.2215\/CJN.00050505","volume":"1","author":"E Bresin","year":"2006","unstructured":"Bresin E et al. (2006) Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: prognostic significance of genetic background. Clin J Am Soc Nephrol 1: 88\u201399","journal-title":"Clin J Am Soc Nephrol"},{"key":"BFncpneph0854_CR62","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.ajkd.2003.07.008","volume":"42","author":"JC Reynolds","year":"2003","unstructured":"Reynolds JC et al. (2003) Thrombotic microangiopathy after renal transplantation in the United States. Am J Kidney Dis 42: 1058\u20131068","journal-title":"Am J Kidney Dis"},{"key":"BFncpneph0854_CR63","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1046\/j.1600-6143.2003.00222.x","volume":"3","author":"V Karthikeyan","year":"2003","unstructured":"Karthikeyan V et al. (2003) Outcome of plasma exchange therapy in thrombotic microangiopathy after renal transplantation. Am J Transplant 3: 1289\u20131294","journal-title":"Am J Transplant"},{"key":"BFncpneph0854_CR64","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1046\/j.1523-1755.1999.00492.x","volume":"55","author":"A Zarifian","year":"1999","unstructured":"Zarifian A et al. (1999) Cyclosporine-associated thrombotic microangiopathy in renal allografts. Kidney Int 55: 2457\u20132466","journal-title":"Kidney Int"},{"key":"BFncpneph0854_CR65","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1053\/ajkd.2003.50058","volume":"41","author":"J Schwimmer","year":"2003","unstructured":"Schwimmer J et al. (2003) De novo thrombotic microangiopathy in renal transplant recipients: a comparison of hemolytic uremic syndrome with localized renal thrombotic microangiopathy. Am J Kidney Dis 41: 471\u2013479","journal-title":"Am J Kidney Dis"},{"key":"BFncpneph0854_CR66","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1681\/ASN.2006050543","volume":"17","author":"G Opelz","year":"2006","unstructured":"Opelz G et al. (2006) No improvement of patient or graft survival in transplant recipients treated with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers: a collaborative transplant study report. J Am Soc Nephrol 17: 3257\u20133262","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl","key":"BFncpneph0854_CR67","doi-asserted-by":"publisher","first-page":"S128","DOI":"10.1097\/01.tp.0000187110.25512.82","volume":"80","author":"S Weber","year":"2005","unstructured":"Weber S and T\u00f6nshoff B (2005) Recurrence of focal-segmental glomerulosclerosis in children after renal transplantation: clinical and genetic aspects. Transplantation 80 (Suppl): S128\u2013S134","journal-title":"Transplantation"},{"key":"BFncpneph0854_CR68","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1111\/j.1600-6143.2005.00968.x","volume":"5","author":"F Vincenti","year":"2005","unstructured":"Vincenti F and Ghiggeri GM (2005) New insights into the pathogenesis and the therapy of recurrent focal glomerulosclerosis. Am J Transplant 5: 1179\u20131185","journal-title":"Am J Transplant"},{"key":"BFncpneph0854_CR69","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1600-6143.2007.02021.x","volume":"8","author":"JM Yabu","year":"2008","unstructured":"Yabu JM et al. (2008) Rituximab failed to improve nephrotic syndrome in renal transplant recipients with recurrent focal segmental glomerulosclerosis. Am J Transplant 8: 222\u2013227","journal-title":"Am J Transplant"},{"key":"BFncpneph0854_CR70","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1007\/s00467-006-0361-6","volume":"22","author":"RN Fine","year":"2007","unstructured":"Fine RN (2007) Recurrence of nephrotic syndrome\/focal segmental glomerulosclerosis following renal transplantation in children. Pediatr Nephrol 22: 496\u2013502","journal-title":"Pediatr Nephrol"},{"key":"BFncpneph0854_CR71","doi-asserted-by":"publisher","first-page":"738","DOI":"10.2215\/CJN.01080905","volume":"1","author":"P Ruggenenti","year":"2006","unstructured":"Ruggenenti P et al. (2006) Rituximab for idiopathic membranous nephropathy: who can benefit? Clin J Am Soc Nephrol 1: 738\u2013748","journal-title":"Clin J Am Soc Nephrol"},{"key":"BFncpneph0854_CR72","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1111\/j.1600-6143.2006.01544.x","volume":"6","author":"L Gallon","year":"2006","unstructured":"Gallon L and Chhabra D (2006) Anti-CD20 monoclonal antibody (rituximab) for the treatment of recurrent idiopathic membranous nephropathy in a renal transplant patient. Am J Transplant 6: 3017\u20133021","journal-title":"Am J Transplant"},{"key":"BFncpneph0854_CR73","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1111\/j.1600-6143.2007.01985.x","volume":"7","author":"D Geetha","year":"2007","unstructured":"Geetha D et al. (2007) Successful induction of remission with rituximab for relapse of ANCA-associated vasculitis post-kidney transplant: report of two cases. Am J Transplant 7: 2821\u20132825","journal-title":"Am J Transplant"},{"key":"BFncpneph0854_CR74","doi-asserted-by":"publisher","first-page":"3550","DOI":"10.1093\/ndt\/gfl506","volume":"21","author":"AE Courtney","year":"2006","unstructured":"Courtney AE et al. (2006) Does angiotensin blockade influence graft outcome in renal transplant recipients with IgA nephropathy? Nephrol Dial Transplant 21: 3550\u20133554","journal-title":"Nephrol Dial Transplant"},{"key":"BFncpneph0854_CR75","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1097\/01.TP.0000061602.03327.E2","volume":"75","author":"HU Meier-Kriesche","year":"2003","unstructured":"Meier-Kriesche HU et al. (2003) Decreased renal function is a strong risk factor for cardiovascular death after renal transplantation. Transplantation 75: 1291\u20131295","journal-title":"Transplantation"},{"issue":"Suppl 3","key":"BFncpneph0854_CR76","first-page":"Siii47","volume":"19","author":"G Fern\u00e1ndez-Fresnedo","year":"2004","unstructured":"Fern\u00e1ndez-Fresnedo G et al. (2004) Proteinuria: a new marker of long-term graft and patient survival in kidney transplantation. Nephrol Dial Transplant 19 (Suppl 3): Siii47\u2013Siii51","journal-title":"Nephrol Dial Transplant"},{"key":"BFncpneph0854_CR77","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1001\/archinte.164.13.1373","volume":"164","author":"C Magee","year":"2004","unstructured":"Magee C and Pascual M (2004) Update in renal transplantation. Arch Intern Med 164: 1373\u20131388","journal-title":"Arch Intern Med"},{"key":"BFncpneph0854_CR78","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1111\/j.1600-6143.2006.01571.x","volume":"6","author":"AJ Matas","year":"2006","unstructured":"Matas AJ (2006) Recurrent disease after kidney transplantation\u2014it is time to unite to address this problem! Am J Transplant 6: 2527\u20132528","journal-title":"Am J Transplant"},{"key":"BFncpneph0854_CR79","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1093\/ndt\/gfg102","volume":"18","author":"J Floege","year":"2003","unstructured":"Floege J (2003) Recurrent glomerulonephritis following renal transplantation: an update. Nephrol. Dial Transplant 18: 1260\u20131265","journal-title":"Nephrol. Dial Transplant"},{"key":"BFncpneph0854_CR80","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1681\/ASN.2004100861","volume":"16","author":"M Noris","year":"2005","unstructured":"Noris M and Remuzzi G (2005) Hemolytic uremic syndrome. J Am Soc Nephrol 16: 1035\u20131050","journal-title":"J Am Soc Nephrol"}],"container-title":["Nature Clinical Practice Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncpneph0854.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpneph0854","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpneph0854.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T11:34:42Z","timestamp":1709033682000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpneph0854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6,17]]},"references-count":80,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["BFncpneph0854"],"URL":"https:\/\/doi.org\/10.1038\/ncpneph0854","relation":{},"ISSN":["1745-8323","1745-8331"],"issn-type":[{"value":"1745-8323","type":"print"},{"value":"1745-8331","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6,17]]}}}